231 related articles for article (PubMed ID: 17295330)
1. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study.
Kimmelstiel C; Gange C; Thaler D
Catheter Cardiovasc Interv; 2007 Apr; 69(5):740-6. PubMed ID: 17295330
[TBL] [Abstract][Full Text] [Related]
2. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
4. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale and migraine.
Post MC; Luermans JG; Plokker HW; Budts W
Catheter Cardiovasc Interv; 2007 Jan; 69(1):9-14. PubMed ID: 17143907
[TBL] [Abstract][Full Text] [Related]
6. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
[TBL] [Abstract][Full Text] [Related]
8. ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine?
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Aggio S; Roncon L
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):633-5. PubMed ID: 17667037
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale and migraine--bringing closure to the subject.
Schwedt TJ; Dodick DW
Headache; 2006 Apr; 46(4):663-71. PubMed ID: 16643562
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of patent foramen ovale in patients with migraine headache.
Spies C; Schräder R
J Interv Cardiol; 2006 Dec; 19(6):552-7. PubMed ID: 17107372
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale in patients with migraine headache. Should it be closed?
Spies C; Kavinsky CJ; Schräder R
Minerva Med; 2007 Feb; 98(1):25-36. PubMed ID: 17372579
[TBL] [Abstract][Full Text] [Related]
13. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.
Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
Catheter Cardiovasc Interv; 2006 Apr; 67(4):625-9. PubMed ID: 16548006
[TBL] [Abstract][Full Text] [Related]
15. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale closure: a new therapy for migraine.
Schwerzmann M; Nedeltchev K; Meier B
Catheter Cardiovasc Interv; 2007 Feb; 69(2):277-84. PubMed ID: 17253601
[TBL] [Abstract][Full Text] [Related]
18. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.
Anzola GP; Frisoni GB; Morandi E; Casilli F; Onorato E
Stroke; 2006 Feb; 37(2):430-4. PubMed ID: 16373630
[TBL] [Abstract][Full Text] [Related]
19. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study.
Vigna C; Marchese N; Inchingolo V; Giannatempo GM; Pacilli MA; Di Viesti P; Impagliatelli M; Natali R; Russo A; Fanelli R; Loperfido F
JACC Cardiovasc Interv; 2009 Feb; 2(2):107-13. PubMed ID: 19463410
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.
Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B
Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
